Regeneron Pharmaceuticals
REGN
#145
Rank
$105.64 B
Marketcap
$962.49
Share price
-0.39%
Change (1 day)
16.39%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2023 (TTM): $4.19 B

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings (TTM) are $4.19 B. In 2022 the company made an earning of $4.85 B a decrease over its 2021 earnings that were of $9.32 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 2001 to 2023

Annual earnings

Year Earnings Change
2023 (TTM)$4.19 B-13.57%
2022$4.85 B-47.9%
2021$9.32 B144.75%
2020$3.81 B56.86%
2019$2.42 B-4.87%
2018$2.55 B22.86%
2017$2.07 B56.3%
2016$1.32 B8.55%
2015$1.22 B54.53%
2014$0.79 B11.14%
2013$0.71 B72.13%
2012$0.41 B-285.93%
2011-$0.23 B121.73%
2010-$0.11 B37.18%
2009-$73.28 M-14.6%
2008-$85.82 M-25.02%
2007-$0.12 B6.32%
2006-$0.11 B-186.52%
2005$0.12 B2103.7%
2004$5.64 M-105.66%
2003-$99.78 M-18.18%
2002-$0.13 B42.33%
2001-$85.69 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$16.97 B 304.16%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.43 B 124.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$7.85 B 87.05%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.39 B 99.92%๐Ÿ‡ซ๐Ÿ‡ท France
$1.29 B-69.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.32 B-107.44%๐Ÿ‡บ๐Ÿ‡ธ USA